LCN2 and breast carcinoma: For instance, using the well-established polyomavirus middle T antigen (MMTV-PyMT) breast carcinoma model, it was shown that crossing MMTV-PyMT mice with Lcn-2−/− mice resulted in a decreased tumor onset and burden compared to wild-type MMTV-PyMT mice.